Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS)
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Life sciences
More from NICE
Home
NICE guidance
In development
In development: Guidance, quality standards and advice
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic prioritisation
Filter (2 applied)
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Expected publication date
Expected publication date
From date
To date
Apply date filters
Area of interest
Area of interest
COVID-19 (1)
Type
(
1 selected
)
Type
Guidance (9)
Guidance programme
Guidance programme
Clinical guidelines (1)
NICE guidelines (2)
Technology appraisal guidance (7)
Apply filters
Showing 1 to 9 of 9
Sort by
Title
Date
Apply sorting
Keyword or reference number: children
Remove Keyword or reference number: children filter
Type: Guidance
Remove Type: Guidance filter
Guidance, NICE advice and quality standards in development
Title
Type
Expected publication date
12 SQ-HDM SLIT for treating allergic rhinitis caused by house dust mites in
children
5 to 11 years ID6510
Technology appraisal guidance
26 August 2026
Dasatinib for treating Philadelphia-chromosome-positive acute lymphoblastic leukaemia in
children
and adults ID1297
Technology appraisal guidance
TBC
Dasatinib for treating Philadelphia-chromosome-positive acute lymphoblastic leukaemia in
children
and adults ID1297
Technology appraisal guidance
28 July 2021
Delandistrogene moxeparvovec for treating Duchenne muscular dystrophy in
children
4 to 7 years ID3897
Technology appraisal guidance
TBC
Epilepsies in
children
, young people and adults
NICE guideline
TBC
Epilepsies in
children
, young people and adults (extraordinary review)
NICE guideline
TBC
Palforzia for treating peanut allergy in
children
aged 1 to 3 [ID6144]
Technology appraisal guidance
TBC
Rivogenlecleucel for treating haematological cancers in
children
and young people undergoing haploidentical haematopoietic stem cell transplant [ID1601]
Technology appraisal guidance
TBC
Rivogenlecleucel for treating haematological non-malignant diseases in
children
and young people undergoing haploidentical haematopoietic stem cell transplant [ID1496]
Technology appraisal guidance
TBC
Current page
1
Page
1
of
1
Results per page
10
25
50
All
Back to top